JAMA 323 (8), 764785
When semaglutide patients switch to tirzepatide In the graph below, you can see that patients who switched from semaglutide to tirzepatide, either because of greater side effects on semaglutide or because they felt they hit a plateau on semaglutide, they continued to lose weight on tirzepatide
Bridging the gap between diabetes and cardiovascular disease: a comparative review of different glucagon-like peptide-1 (GLP-1) agonists: efficacy, safety, and patient outcomes
Brain health is central to maintaining optimal cognitive function, mental well-being, and overall physical capabilities
The article names patient assistance programs, manufacturer coupons, and discount pharmacy networks such as GoodRx, RxSaver, and SingleCare as options that may reduce branded costs
Ameliorating effects of L-carnitine on diabetic podocyte injury